Navigation Links
Transgenomic Reports Second Quarter Financial Results
Date:8/11/2011

s beginning at 5:00 p.m. Eastern time today. To access the call via telephone, please dial 800-895-0198 from the U.S. and Canada or 785-424-1053 for international participants and enter the conference ID TRANS. The call also will be broadcast live over the Internet. To listen to the webcast, please log onto the Company's Investor Relations web page at http://www.transgenomic.com/events.asp?id=6 and follow the instructions. An archived webcast of the call will be available for 30 days. Investors can listen to a replay via telephone until 11:59 p.m. Eastern time on Thursday, August 25, 2011 by dialing 800-374-1375 (domestic) or 402-220-0682 (international).

About TransgenomicTransgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The company has three complementary business divisions: Transgenomic Pharmacogenomic Services is a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development. Transgenomic Clinical Laboratories specializes in molecular diagnostics for cardiology, neurology, mitochondrial disorders, and oncology. Transgenomic Diagnostic Tools produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The company actively develops and acquires new technology and other intellectual property that strengthen its leadership in personalized medicine.

Forward-Looking StatementsCertain statements in this press release constitute "forward-
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Transgenomic to Hold First Quarter Financial Results Conference Call on May 12, 2011
2. Transgenomic, Inc. Enhances FAMILION® Genetic Test Offerings
3. Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting
4. Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%
5. Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
6. Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
7. Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17
8. Transgenomic Reports Third Quarter Financial Results
9. Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act
10. Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
11. Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Tenn. (PRWEB) July 29, 2014 ... in biomass feedstock supply innovation and supply chain ... proprietary feedstock management systems, Energy Grange™ and Supply ... of R&D and in-the-field testing aimed at consolidating ... offering benefits to landowners, farmers and feedstock end ...
(Date:7/29/2014)... SILVER SPRING, Md., July 29, 2014  United ... today announced its financial results for the ... "Our continued growth shows that our medicines ... from pulmonary arterial hypertension (PAH)," said Martine ... Executive Officer. "The commercial launch this quarter ...
(Date:7/29/2014)... The prestigious "Discovery or Exploration in History ... to Juliana Hillis and Kaylie O’Connell, students at Stoneham ... an Egg, Everything: America’s First IVF Baby". This project ... National History Day program during a week-long final competition ... Washington, D.C. , The growing popularity of the assisted ...
(Date:7/29/2014)... , July 29, 2014 ... Biopsy System (LBS) zur Erfassung biologischer Daten ... Herzkranzgefäßen entwickelt und patentiert. Das LBS nimmt ... der Koronararterie des Patienten und sucht erhöhte ... hat das Potenzial, die Entdeckung und Entwicklung ...
Breaking Biology Technology:Genera Energy Introduces Proprietary Feedstock Management Systems 2Genera Energy Introduces Proprietary Feedstock Management Systems 3Genera Energy Introduces Proprietary Feedstock Management Systems 4United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 11United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 12United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 13In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 4
... the French get away with a clean bill of heart ... answer to the so-called "French paradox" may be found in ... of resveratrol, a natural constituent of grapes, pomegranates, red wine ... international team of researchers. , Writing this week (June 3) ...
... Calif., June 3 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... development leadership team with the appointment of industry,veterans ... Research and,Development and Mary G. Bolton, M.D., Ph.D., ... Fox, Ph.D., has been promoted to Vice,President, Product ...
... /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI , ... identifies,develops and commercializes differentiated products for patients worldwide,today ... of its,anti-cancer drug nimotuzumab, a humanized monoclonal antibody ... at the 2008 American,Society of Clinical Oncology (ASCO) ...
Cached Biology Technology:Agent in red wine found to keep hearts young 2Agent in red wine found to keep hearts young 3Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595) 2Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595) 3Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595) 4Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595) 5Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595) 6NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 2NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 3NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING 4
(Date:7/28/2014)... The findings of a new study suggest two ways to ... work as well in obese women, compared to women of ... a one-size-fits-all method, researchers say, but as the population has ... pill works for obese women. Studies have consistently found that ... body, which may in turn affect how well the pill ...
(Date:7/28/2014)... Kansas He calls himself the bug hunter, but ... can only be found and identified with special methods ... the Kansas State Veterinary Diagnostic Laboratory at Kansas State ... discoveries, porcine enterovirus G, which is an important find ... virus in cells, but didn,t know what it was," ...
(Date:7/28/2014)... 2014) Rice University researchers are using magnetic beads ... that can be used as microscale models for polymer ... polymers, introduced as theory in the 1950s, can be ... should be of interest to materials scientists who study ... by Rice chemical and biomolecular engineer Sibani Lisa Biswal ...
Breaking Biology News(10 mins):Strategies identified to improve oral contraceptive success with obese women 2Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3Seeing is bead-lieving 2
... Institutes of Health today is hosting the launch of ... poverty and human development, to coincide with the publication ... Seven of the most outstanding articles examining interventions and ... the poor are being presented at the event. The ...
... has joined forces with the world,s largest agribusiness ... an economical, green fuel alternative for cars. ... dollar deal between QUT, qutbluebox, Syngenta and Farmacule ... see the establishment of the "Syngenta Centre for ...
... of researchers led by a Fred Hutchinson Cancer ... to a disabling form of arthritis called ankylosing ... some or all of the spines vertebrae fuse ... two genes implicated in Graves disease, an autoimmune ...
Cached Biology News:NIH hosts event to launch Council of Science Editors' global theme issue 2NIH hosts event to launch Council of Science Editors' global theme issue 3Global deal fuels QUT's world-changing research 2Study reveals 2 genes linked to disabling arthritis 2Study reveals 2 genes linked to disabling arthritis 3
Request Info...
... is able to accept cell lines produced according ... cell lines must be accompanied by a certificate ... with the requirements of cGMP and that they ... or fungi. What are the benefits of the ...
Cells are grown in triple flasks or roller bottles. Viability and growth data are generated from a parallel representative culture....
... T7Select Packaging Extracts are optimized for maximum ... insert. The high efficiency extracts (> 109 ... to produce a library containing at least ... arms. The extracts are made from a ...
Biology Products: